Clinic of Hematology and Oncology

Research output

Research output per year 1997 2018 2020 2021 2022 2023 2024

• 6312 Citations
• 287 Journal articles
• 27 Scientific review articles
• 13 Letters
• 2 Chapter
• 4 More
  • 2 Editorial
  • 1 Comments/Debates
  • 1 Short survey

Research output per year

Research output per year

Search results

• 2018

  Ponatinib: A third-generation inhibitor for the treatment of CML

  Wehrle, J. & von Bubnoff, N., 2018, Recent Results in Cancer Research. Springer New York LLC, p. 109-118 10 p. (Recent Results in Cancer Research; vol. 212).

  Research output: Chapters in Books/Reports/Conference Proceedings › Chapter › peer-review

  • ponatinib 100%
  • bosutinib 16%
  • 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide 14%
  • Dasatinib 13%
  • Cohort Effect 13%
  5 Citations (Scopus)

• Ruxolitinib

  Ajayi, S., Becker, H., Reinhardt, H., Engelhardt, M., Zeiser, R., von Bubnoff, N. & Wäsch, R., 2018, Recent Results in Cancer Research. Springer New York LLC, p. 119-132 14 p. (Recent Results in Cancer Research; vol. 212).

  Research output: Chapters in Books/Reports/Conference Proceedings › Chapter › peer-review

  • INCB018424 100%
  • Primary Myelofibrosis 60%
  • Polycythemia Vera 41%
  • Splenomegaly 18%
  • Janus Kinase 1 12%
  19 Citations (Scopus)